589 related articles for article (PubMed ID: 33912129)
1. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.
Pacheco-Herrero M; Soto-Rojas LO; Harrington CR; Flores-Martinez YM; Villegas-Rojas MM; León-Aguilar AM; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Corniel-Taveras CN; Dominguez-García JJ; Blanco-Alvarez VM; Luna-Muñoz J
Front Neurol; 2021; 12():660087. PubMed ID: 33912129
[TBL] [Abstract][Full Text] [Related]
2. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration.
Rodriguez M; Soler Y; Perry M; Reynolds JL; El-Hage N
Front Neurol; 2020; 11():583459. PubMed ID: 33304309
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
4. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses.
Barrantes FJ
ACS Chem Neurosci; 2020 Sep; 11(18):2793-2803. PubMed ID: 32845609
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
7. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
9. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
10. Review of Neurological Manifestations of SARS-CoV-2.
Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
[TBL] [Abstract][Full Text] [Related]
11. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
12. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
13. Neurological manifestations and pathogenic mechanisms of COVID-19.
Galea M; Agius M; Vassallo N
Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
[TBL] [Abstract][Full Text] [Related]
14. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
Baig AM
ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
16. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
Szabo MP; Iba M; Nath A; Masliah E; Kim C
Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
[TBL] [Abstract][Full Text] [Related]
17. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
19. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
Parit R; Jayavel S
Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
[TBL] [Abstract][Full Text] [Related]
20. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
Yang F; Zhao H; Liu H; Wu X; Li Y
Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
